Login / Signup

Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease.

Iskra PusicCatherine LeeMuthu VeeraputhiranChelsea MinorJohn F Dipersio
Published in: Bone marrow transplantation (2023)
Keyphrases
  • combination therapy